Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
Links shared publicly online about this topic.
- 985total visits
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
fda.gov —
View full resource at fda.gov
Most Recently Shared on July 30, 2010 at 11:40 am By:
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia: Cases of serious, potentially ... http://bit.ly/bTeVBr
Eosinophilic Pneumonia Linked With Cubicin Use
medicalnewstoday.com — “FDA releases drug safety communication warning of potential to acquire this serious condition when receiving intravenous antibacterial daptomycin.Patients and health professionals have” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 12:05 pm By:
MNT Infect Diseases Health News
Eosinophilic Pneumonia Linked With Cubicin Use http://mnt.to/3GSp #viruses #bacteria
FDA: Eosinophilic pneumonia may be linked to daptomycin use | HemOncToday
hemonctoday.com — “The FDA has issued a drug safety communication about the potential for developing eosinophilic pneumonia while being treated with daptomycin,” View full resource at hemonctoday.com
Most Recently Shared on July 30, 2010 at 4:18 pm By:
HemOnc Today Oncology and Health News
#FDA: Eosinophilic pneumonia may be linked to daptomycin use http://ht.ly/2iUgs
Advertisement
